These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4958046)

  • 1. Selective effects of nitrofuraldoxime-anti on isoniazid resistant m. tuberculosis.
    Wayne LG; Russell RL
    Scand J Respir Dis; 1966; 47(1):18-26. PubMed ID: 4958046
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of DNA-tropic substances used jointly with tuberculostatic preparations on the development of drug resistance in Mycobacterium tuberculosis].
    Il'ina TB; Vishnevskiĭ BI
    Probl Tuberk; 1980 May; (5):67-70. PubMed ID: 6770368
    [No Abstract]   [Full Text] [Related]  

  • 3. [Change in drug resistance of Mycobacterium tuberculosis in experimental studies].
    Dushkevich AK; Bartashevich TA
    Probl Tuberk; 1974; (11):78-82. PubMed ID: 4217456
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of pH of the medium and other factors on the selection of isoniazid-resistant forms of M. tuberculosis].
    Dolzhanskiĭ VM
    Probl Tuberk; 1975; (9):68-71. PubMed ID: 6956
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mycobacterium tuberculosis resistant drugs and their effect on guinea pigs inoculated with a mixture of sensitive and resistant M. tuberculosis].
    Belogurova VP
    Antibiotiki; 1971 May; 16(5):429-33. PubMed ID: 5002222
    [No Abstract]   [Full Text] [Related]  

  • 6. [Significance of homogenizing factors and of media in the isolation od INH-resistant tubercle bacilli].
    Zduńcyk-Pawelek H; Antosiewicz-Roszkiwska A; Blitek-Golc D
    Gruzlica; 1975 May; 43(5):433-40. PubMed ID: 806488
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug resistance of Mycobacterium tuberculosis].
    Malaguzzi Valeri F; Rossi F
    G Pneumol; 1970 Apr; 14(2):121-5. PubMed ID: 5005066
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on mutation of isoniazid resistant genes in M. tuberculosis].
    Yao MH; Lou YH
    Hunan Yi Ke Da Xue Xue Bao; 2001 Jun; 26(3):195-6. PubMed ID: 12536677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biological properties of Mycobacterium tuberculosis in relation to sensitivity to antibacterial preparations].
    Gol'shevskaia VI; Grishina TA; Karpenko OL; Safonova SG; Grishina TD
    Probl Tuberk; 1995; (4):37-40. PubMed ID: 7567869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biological properties of drug-sensitive Mycobacterium tuberculosis].
    Ginzburg TS; Klimenko MT; Sokalo SV
    Probl Tuberk; 1986; (7):58-60. PubMed ID: 3094003
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study of the biological characteristics of strains of M. tuberculosis resistant to isoniazid and rifampin].
    Diaconescu C; Iacob L
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1984; 33(2):151-62. PubMed ID: 6093222
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study on the mutations of ahpC genes in M. tuberculosis isoniazid-resistant isolates].
    Wu X; Zhang J; Hu Z
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Dec; 21(12):727-9. PubMed ID: 11480074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of protegrin-1 and beta-defensin-1, alone and in combination with isoniazid, against Mycobacterium tuberculosis.
    Fattorini L; Gennaro R; Zanetti M; Tan D; Brunori L; Giannoni F; Pardini M; Orefici G
    Peptides; 2004 Jul; 25(7):1075-7. PubMed ID: 15245864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect on Mycobacterium tuberculosis of rifamycin SV alone and combined with major bacillostatic agents].
    Coletsos PJ
    Rev Tuberc Pneumol (Paris); 1967; 31(1):17-30. PubMed ID: 4962522
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experimental tuberculosis produced by phthivazid-resistant mutants of the culture H 37 Rv].
    Zemskova ZS; Sergeev VV
    Probl Tuberk; 1967; 45(9):77-82. PubMed ID: 4974608
    [No Abstract]   [Full Text] [Related]  

  • 16. Increasing drug resistance of Mycobacterium tuberculosis isolates in Ontario, Canada, 1987-1998.
    Remis RS; Jamieson F; Chedore P; Haddad A; Vernich L
    Clin Infect Dis; 2000 Aug; 31(2):427-32. PubMed ID: 10987700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sensitivity to chemotherapeutic agents of Mycobacterium tuberculosis after brief stay in the organism of albino mice].
    Zueva VS; Solov'ev VN
    Antibiotiki; 1968 Apr; 13(4):355-9. PubMed ID: 4970747
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative study of bactec MGIT 960 AST and conventional proportion method using Ogawa medium for the drug susceptibility testing of Mycobacterium tuberculosis to isoniazid].
    Mitarai S; Kobayashi I; Abe C; Wada M; Suzuki K; Takashima T; Kawabe Y; Machida K; Tano M; Takigawa S; Kamada A; Shigetoh E; Fujii S; Mori K; Suyama H; Yano S; Kawashiro T; Ogata H
    Kekkaku; 2007 May; 82(5):449-54. PubMed ID: 17564123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late emergence of isoniazid-susceptible organisms in guinea pigs challenged with a homogeneous isoniazid-resistant strain on Mycobacterium tuberculosis.
    Noufflard-Guy-Loe H; Berteaux S
    Am Rev Respir Dis; 1966 Oct; 94(4):540-52. PubMed ID: 4958873
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical significance of the degree of resistance of tubercular mycobacteria to specific chemoantibiotics (clinical note)].
    Lucchesi M; Mancini P; Sbampato M
    Ann Ist Carlo Forlanini; 1968; 28(1):74-90. PubMed ID: 4985828
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.